Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association

Ndumele, Chiadi E., Rangaswami, Janani, Chow, Sheryl L., Neeland, Ian J., Tuttle, Katherine R., Khan, Sadiya S., Coresh, Josef, Mathew, Roy O. +22 more·2023·Circulation

DOI 10.1161/cir.0000000000001184

Cited by (1,000)

Items 701–800 of 1,000

Efficacy, Quality of Life, and Cost‐Effectiveness of Superselective Adrenal Arterial Embolization in Idiopathic Hyperaldosteronism: A Comparative Study
Nouman Ali Khan, Min Mao, Rui Feng, Zhong Zuo, Muhammad Arif Asghar, Tao Li, Yongpeng Zhao, Ping Tang, Zhiyong Xu, Jie Chen et al. · 2025 · Journal of Clinical Hypertension
Renal Dysfunction, Coronary Artery Lesion Complexity, and Adverse Cardiovascular Outcomes in Patients With Acute Coronary Syndrome
Qiang Chen, Yike Li, Siqi Yang, Haoming He, Yingying Xie, Wei Wang, Long Wang, Yanxiang Gao, Lin Cai, Shiqiang Xiong et al. · 2025 · Reviews in Cardiovascular Medicine
Optimizing Care for Cardiovascular-Kidney-Metabolic Syndrome: Leveraging Implementation Science in the Path Toward Pharmacoequity
Regina M. Longley, Cecilia Katzenstein, Dinushika Mohottige · 2025 · Current Cardiology Reports
State‐level prevalence of chronic conditions co‐occurring with obesity among US adults
Lixia Zhao, Alyson B. Goodman, Xin Tong, Stephen John Onufrak, Samantha Lange Pierce, Reena B. Oza‐Frank, Carlen Stadnik, Brook Belay, Heidi M. Blanck · 2025 · Diabetes Obesity and Metabolism
The nonlinear association between the triglyceride glucose-waist-to-height ratio index and cardiovascular disease among middle-aged and older adults in China with cardiovascular-kidney-metabolic syndrome stages 0–3
Cheng Huang, Jing Jia, Yuanyuan He · 2025 · Frontiers in Cardiovascular Medicine
Early-Life Hydrogen Sulfide Signaling as a Target for Cardiovascular–Kidney–Metabolic Syndrome Reprogramming
Chien‐Ning Hsu, Ying-Jui Lin, Chih‐Yao Hou, Yu‐Wei Chen, You‐Lin Tain · 2025 · Antioxidants
Novel Strategies to Conquer Residual Adiposity Risk in Cardiovascular Disease
Jerrin S. Philip, Aayush Shah, Eleonora Avenatti · 2025 · Current Atherosclerosis Reports
Uric acid and uric acid/creatinine ratio are associated with GDM in women undergoing IVF/ICSI
Yvonne Liu, Johann-Georg Hocher, Shujuan Ma, Liang Hu, Huijun Chen, Xiaoli Zhang, Fei Gong, Bernhard Krämer, Ge Lin, Berthold Hocher · 2025 · Frontiers in Endocrinology
Sleep traits and the longitudinal progression of cardio-renal-metabolic multimorbidity: A prospective study from UK-Biobank
Yali Niu, Tianrun Wang, Xiaocan Jia, Chaojun Yang, Jingwen Fan, Chenyu Zhao, Nana Wang, Zhixing Fan, Xuezhong Shi · 2025 · Sleep Health
Tackling the Cardio-Kidney-Metabolic Burden in Cancer
Tarek Nahle, Viraj Shah, Harikrishnan Hyma Kunhiraman, Omar Mohamed Makram, Ola Ahmed, Sandeep Yerraguntla, Gaurav Gopu, Jenny Vy, Shivam Singh, Tanvi Borse et al. · 2025 · Current Atherosclerosis Reports
The cardiovascular–kidney–metabolic staging in type 2 diabetes: the clock starts ticking early
Karolina Hoffmann, Anna Paczkowska, Viviana Maggio, Manfredi Rizzo · 2025 · Journal of Diabetes and its Complications
Optimising Access to Care for Patients with Heart and Kidney Diseases: A World Heart Federation and International Society of Nephrology White Paper
Jagat Narula, Javed Butler, Mogamat‐Yazied Chothia, Debasish Bannerjee, Faiçal Jarraya, Ifeoma Ulasi, Valérie A. Luyckx · 2025 · African Journal of Nephrology
Impaired Kidney Function, Subclinical Myocardial Injury, and Their Joint Associations with Cardiovascular Mortality in the General Population
Ahmed E. Shatta, Mohamed A. Mostafa, Mohamed A. Attia, Tarek Ahmad Zaho, Richard Kazibwe, Elsayed Z. Soliman · 2025 · Journal of Clinical Medicine
Nonlinear association between triglyceride-glucose index and risk of hyperuricemia in early-stage cardiovascular-kidney-metabolic syndrome: a cross-sectional study of United States population
Xinyang Chen, Yan Liang · 2025 · Frontiers in Cardiovascular Medicine
Cardiovascular-kidney-metabolic syndrome: the interdisciplinary approach. A review
O. Iu. Trushina · 2025 · Terapevticheskii arkhiv
Safety and Efficacy of Intensive BP Control in Cardiovascular-Kidney-Metabolic Syndrome
Yuzhe Yin, Xiaopu Wang, Keyang Zheng, Tienan Sun, Biyang Zhang, Rite Si, Jingyi Xiao, Yuning Jiao, Shunwei Wang, Yunwen Wang et al. · 2025 · Journal of the American College of Cardiology
Pituitary adenylate cyclase-activating polypeptide (PACAP) attenuates diabetic cardiomyopathy via Nrf2/HO-1 antioxidant signaling and NF-κB-mediated inflammation suppression in streptozotocin-treated mice
Dong Yang, Huozhao Ruan, L Chen, Haonan Zhang, Guiying Liu · 2025 · Neuropeptides
Associations of lipid-lowering drugs with cardiovascular-kidney-metabolic syndrome: A drug-target Mendelian randomization study
Mengjin Hu, Zhaoting Gong, Xiaosong Li, Jinggang Xia, Chunlin Yin · 2025 · Journal of clinical lipidology
Non-linear associations and threshold effects of oxidative balance score and composite dietary antioxidant index on frailty risk in patients with cardiovascular-kidney-metabolic syndrome
Zheng Wang, Lei Fang, Long Wang, Jing Zhang · 2025 · Frontiers in Nutrition
Current and Emerging Roles of GLP1 Receptor Agonists Across the Spectrum of Left Ventricular Ejection Fraction in Heart Failure
Simone Pasquale Crispino, Annunziata Nusca, Aurora Ferro, Riccardo Cricco, Martina Ciancio, Andrea Segreti, Ilaria Cavallari, Mario Sabatino, Luciano Potena, Gian Paolo Ussia et al. · 2025 · Biomolecules
Association between systemic inflammation response index and advanced stages in U.S. cardiovascular-kidney-metabolic syndrome patients: a cross-sectional study using NHANES 2015–2020 data
Jing Zhang, Dingyuan Tu · 2025 · BMC Cardiovascular Disorders
Prognostic impact of heart failure, chronic kidney disease and atherosclerotic disease alone or combined in an elderly population: a retrospective cohort study based on electronic health record data
João Pedro Ferreira, Tiago Taveira‐Gomes, Rita Lopes, Daniel Seabra, Filipa Bernardo, Cristina Gavina · 2025 · BMJ Open
Global burden of 13 non-communicable diseases attributable to high fasting plasma glucose from the GBD 2021 study
Junfeng Zhou, Zhengbin Yao, Shugen Xu, Yong Long, Zhao Zeng, Jiao Qin, Ning Ding, Yingjie Su · 2025 · Nutrition and Diabetes
Deltan polyherbal formula offers multifaceted protection against cardiometabolic syndrome via metabolic and microbiome rebalancing
Vito Anggarino Damay, Juan Leonardo, Axel Brahmantyo Maynardo Nugroho, Vincent Lau, Arditya Damarkusuma, Dante Saksono Harbuwono, Sidartawan Soegondo, Happy Kurnia Permatasari, Ratna Karuna, Nurpudji Astuti Taslim et al. · 2025 · Phytomedicine Plus
Associations of air pollutant exposures with Cardio-Kidney-Metabolic syndrome in Chinese middle-aged and older adults: a cross-sectional study based on CHARLS
Yilin Pan, Jingru Bi, Zhaobin Sun, JinYuan Xin, Xiaonan He · 2025 · BMC Public Health
Neutrophil percentage to albumin ratio and advanced cardiovascular-kidney-metabolic syndrome in diabetes: a machine learning approach
Zifan Zhuang, Xinyao Liu, Hongrui Lu, Qian Wu, Yupeng Chen, Qing Yong Ni · 2025 · European journal of medical research
Longitudinal correlation between cumulative remnant cholesterol inflammatory index and incident diabetes
Qiqiang Li, Li Gong, Hongxin Li · 2025 · Diabetology & Metabolic Syndrome
Association between the oxidative balance score and all-cause and cardiovascular mortality in patients with cardiovascular-kidney-metabolic syndrome——a retrospective cohort study from the NHANES
Kun Peng Cheng, Kun-xia Lin, Xiaofen Zhou, Han Chen · 2025 · BMC Cardiovascular Disorders
A Systematic Literature Review of Coordinated Care in Cardiovascular-Kidney-Metabolic Conditions
O. Duru, Radica Z. Alicic, M. Vaduganathan, W. St. Peter, Glenda V. Roberts, Janani Rangaswami, Susanne B. Nicholas, J. Neumiller, Roy O Mathew, Patrick Gee et al. · 2025 · Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Low education and employment status drive cardiometabolic health: a social determinants perspective in Chinese population
Jiafeng Zhang, Xin-yi Cai, Wei Tang, Yan Song, Xing-xing Zhang, Yongquan Shi, Tuo Li · 2025 · Frontiers in Public Health
Cardiovascular‐Kidney‐Metabolic Syndrome in People With HIV : An Emerging Frontier for Clinical Pharmacology
Aaron S. Devanathan, Thomas D. Nolin · 2025 · Clinical Pharmacology & Therapeutics
Association of dietary patterns with all-cause and cardiovascular disease mortality in cardiovascular-kidney-metabolic syndrome: a cohort study
Ya Shao, Yu Wang, Desheng Luo, Xu Zhou, Maoqian Chen, Longti Li, Huiqin Zhong · 2025 · Nutrition Journal
Association between triglyceride–glucose muscle-loss index (TyG–MLI) and incident cardiovascular disease: a prospective cohort study in the UK biobank
Yanwen Fang, Sizhuang Huang, Hao Zhang, Mingyang Li, Haihua Zhang, Weixian Yang, Mengyue Yu · 2025 · Cardiovascular Diabetology
Prognostic significance of the CALLY index for mortality among patients with cardiovascular–kidney–metabolic syndrome stages 0–3
Mingshen Lin, Shuaiqing Chen, Jing Ye, Xiaohan Hu · 2025 · Diabetology & Metabolic Syndrome
Long-term exposure to ambient air pollution and incident cardiovascular disease in adults with cardiovascular–kidney–metabolic stages 0–3: a nationwide prospective cohort study in China
Wei Li, Fangfang Lou, Xiaoyi Liu, Wenfeng Ye, Yunshi Lai, Zijie Liang, Huishi Li, Xuefang Huang, Peiyi Ye, Yaozhong Kong et al. · 2025 · Scientific Reports
SDOH, healthy lifestyle, and life expectancy in adults with CKM syndrome: two cohort studies
Qiong Huang, Wenbin Nan, Baimei He, Zhenyu Peng · 2025 · Progress in Cardiovascular Diseases
Cardiovascular risk across stages of cardiovascular-kidney-metabolic syndrome in South Korea, 2002–2022: A population-based cohort study
Jaehyeong Cho, Tae Hyeon Kim, Yejun Son, Yesol Yim, Jeongseon Oh, Hyunjee Kim, Jinyoung Jeong, Jiyeon Oh, Sooji Lee, Louis Jacob et al. · 2025 · Medicine
Air pollution promotes the onset and progression of cardiovascular-kidney-metabolic syndrome: a nationwide prospective cohort study
Chen Gui, Zhuotao Xiao, Mohan Li, Junwei Xu · 2025 · BMC Public Health
PaCE CKD: A Multinational Survey of Financial Burden and Work Productivity in Patients with Chronic Kidney Disease and Caregivers
Steven James Chadban, Ciro Esposito, Ricardo Correa‐Rotter, Mai-Szu Wu, Helmut Reichel, Hesham Mohamed Elsayed, Juan José García Sánchez, Surendra Pentakota, Thames Kularatne, Simon J. Fifer et al. · 2025 · Advances in Therapy
MAFLD increases CKM syndrome severity: a NHANES-based cross-sectional study
Alaa Mohamed Mostafa, Yasser Mahrous Fouad, Ziayn Pan, Shereen Abdel Alem, Mohamed AbdAllah, Eman Abdelsameea, Mohammed Eslam · 2025 · Clinical and Experimental Medicine
Association of cardiovascular–kidney–metabolic syndrome stages with mortality: A nationwide, population-based, prospective cohort study
Xingyu Zhou, Rui Zhu, Lili Liu, Xuejiao Liu, Jiapeng Lu, Bowang Chen, C Y Wu, Xiaoyan Zhang, Yang Yang, Jianlan Cui et al. · 2025 · Chinese Medical Journal
Associations of modifiable lifestyle behaviors with cardiovascular–kidney–metabolic syndrome across risk categories: Findings from a U.S. national survey
Xin Chen, Xinyu Tao, Zhonghua Sun, Hanning Xiong, Yameng Xu, Ying Xu, Zhengxia Liu, Chen Qu, Biao Xu · 2026 · Heart & Lung
Insulin-resistance indices and cardiovascular mortality in cardiovascular–kidney–metabolic syndrome stage 2: a comparative analysis of eGDR, TyG and METS-IR
Chuanwei Zhao, Honglin Li, Xichao Jiang, Yane Yang, Yunjie Yang, Handan Zhang, Xiaochun Zhang, Xu Zhang, Mu Lin · 2026 · Diabetology & Metabolic Syndrome
Adverse childhood experiences and cardiovascular disease risk in early-stage CKM: The mediating role of depressive symptoms
Zengyu Chen, Wei Jiang Zhao, Zeping Chen, Kaixin Tian, Yalu Qin, Ya Yu, Rui Xie · 2026 · General Hospital Psychiatry
Association between the frailty index and all-cause and cardiovascular mortality in a population with cardiovascular-kidney-metabolic syndrome: Insights from the NHANES 2011-2018
Xin Wang, Xinrui Hai, Ali Ma, Xiaolan Liang, Hua Cheng, Peng Sen Wu, Yu Hao, Dapeng Chen, Ning Yan · 2026 · The Journal of Frailty & Aging
The Role of Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Cardiovascular-Kidney-Metabolic Syndrome
Sonal Rajesh Kumar, John E. Anderson, Andrea D. Coviello, F. Lopez-Jimenez, George L. Bakris · 2026 · JACC Advances
The urinary albumin‐to‐creatinine ratio can direct personalized prevention and treatment for cardiovascular and chronic kidney disease
Holly J. Kramer, George L. Bakris · 2026 · Journal of Internal Medicine
Performance of the Predicting Risk of Cardiovascular Disease Events Calculator in Rheumatoid Arthritis
Tate M. Johnson, Halie Frideres, Punyasha Roul, Joshua F. Baker, Brian C. Sauer, Grant W. Cannon, Isaac D. Smith, Gary A. Kunkel, Beth I. Wallace, Thomas R Porter et al. · 2026 · Arthritis & Rheumatology
Association of remnant cholesterol inflammation index with future cardiovascular disease risk in patients with cardiovascular-kidney-metabolic syndrome stages 0–3
Nanshan Xie, Lihuan Zeng, Xiangming Hu, Zejia Wu, Weiling Lu, Songyuan Luo, Jianfang Luo · 2026 · Diabetes Research and Clinical Practice
GLP-1 RAs vs. SGLT2is: Divergent pathways of cardiovascular inflammation control in obesity-associated diabetes
Ailish Hephzibah Samuel, Abhishek Hanumanpratap Singh Kshatri, Rithwik Nanda Babu, Harsh Shirishkumar Patel, Smera Hari Viswanathan, Mani Shankar Reddy Challa, N. L. Swathi · 2026 · Annales d Endocrinologie
Triglyceride-glucose index and its derivatives as emerging biomarkers of insulin resistance for prognostic evaluation of cardiovascular-kidney-metabolic syndrome: mechanisms and clinical applications
Zhiming Zheng, Xueshi Yin, Jianping Liu, Yongheng Zhang · 2026 · Frontiers in Pharmacology
The remnant cholesterol inflammatory index and risk of future cardiovascular disease in early CKM syndrome: findings from CHARLS
Yue Yu, Yuemiao Jiao, Sanshuai Chang, Y G Li, Ke Shang, Guangyuan Song, Chengqian Yin · 2026 · Journal of Health Population and Nutrition
Prevalence and influence of cardiovascular kidney metabolic syndrome on outcomes after transcatheter aortic valve implantation
Felix Götzinger, Thorald Stolte, Jakob Johannes Reichl, Anke von Peter, Michael Kunz, Mirjam Gauri Wild, Max Wagener, Christoph Kaiser, Christian Eugen Mueller, Dirk Westermann et al. · 2026 · European Journal of Heart Failure
Nonlinear association between triglyceride–glucose frailty index and new-onset stroke in adults at cardiovascular–kidney–metabolic syndrome stages 0–3: a CHARLS cohort study
Jun Wei, Yang Liu · 2026 · Maturitas
Associations of visceral fat accumulation with cardiovascular disease across cardiovascular-kidney-metabolic syndrome stages 0–3: mediation effects of arterial stiffness in a prospective cohort study
Ke Wang, Xinyao Luo, Dingyuan Wan, Baihai Su, Yupei Li · 2026 · BMC Cardiovascular Disorders
Sweet relief: exploring mechanisms and therapeutic approaches of sodium-glucose cotransporter-2 inhibitors in cardiovascular-kidney metabolic syndrome
Jiaxin Hua, Qingyuan Wang, Ye Liu, Shengwei Luo, Ao Shi, Zhiwei Yan, Jing Zhang, Wenli Gu, Lihan Zhu, Yuling Zhang et al. · 2026 · Cardiovascular Diabetology
Sodium–glucose cotransporter 2 inhibitors across cardio-reno-metabolic disease and body mass index: a meta-analysis of randomized controlled trials
Dimitrios T. Farmakis, Konstantinos I. Karampinos, Chris J. Kapelios, Sotiria Liori, Katerina Fountoulaki, Gerasimos S Filippatos · 2026 · European Heart Journal - Quality of Care and Clinical Outcomes
Cardiovascular-Kidney-Metabolic Syndrome: Development of an ICD-10-CM Coding Framework
MINZHE ZHAO, Junhao Zhang, Huiyun Wang, Chongjun Xu, Jiahui Li, Chenghua Li, X He, Xueying Zheng · 2026 · JMIR Diabetes
Atherogenic Index of Plasma Predicts the Onset and Progression of Cardio‐Renal‐Metabolic Multimorbidity: Evidence From a Nationwide Prospective Cohort Study
Jijie Jin, Fang Wang, Shengzhang Chen, Jiaxin Shao, Binyan Chen, Xiufang Lin · 2026 · Journal of Diabetes
Natural Language Processing of Unstructured Healthcare Data for Predicting Heart Failure in Individuals with Type 2 Diabetes
Juan F. Navarro‐González, Leopoldo Pérez de Isla, Gloria Cánovas Molina, Miguel Ángel Brito-Sanfiel, David E. Barajas Galindo, Luis Cuéllar, Dı́dac Mauricio, Santiago Tofé, José Antonio Balsa Barro, Matilde Rubio-Almanza et al. · 2026 · Journal of Clinical Medicine
Health Care Affordability in the United States, From Crisis to Action: A Presidential Advisory From the American Heart Association
Dhruv S. Kazi, Joshua A. Beckman, Regina M. Benjamin, Grace Firestone, Janay C Johnson, Mark McClellan, Neil Meltzer, Anne Oxrider, Stacey Ellyn Rosen, Bertram L Scott et al. · 2026 · Circulation
Cardio-Kidney-Metabolic Phenotypes and Adverse Clinical Outcomes in Patients With Atrial Fibrillation
Jung‐Chi Hsu, Chih‐Kuo Lee, Yen-Yun Yang, Shu-Lin Chuang, Jen‐Kuang Lee, Fu‐Chun Chiu · 2026 · JACC Asia
Precision Medicine to Redefine Insulin Secretion and Monogenic Diabetes (PRISM): A Randomized Controlled Trial in Chinese Patients With Young-Onset Diabetes
Andrea O. Y. Luk, Chun Kwan O, Baoqi Fan, Eric S. H. Lau, Yingnan Fan, Cadmon Lim, Juliana Nga Man Lui, Kelly TC. Wong, Sandra T.F. Tsoi, Emily Poon et al. · 2026 · Diabetes Care
Beyond eGFR and Albuminuria: Biological Pathways and Multiomics in Cardiovascular–Kidney–Metabolic Disease
William R. Marshall, Thomas McDonnell, Darren Green, Smeeta Sinha, Philip A. Kalra · 2026 · Kidney International Reports
Weight Loss–Independent Mechanisms of Kidney Protection With Glucagon-Like Peptide 1 Receptor Agonists and Implications for Clinical Practice
Allon N. Friedman, Ilyas Oultache, Robert Hovey · 2026 · American Journal of Kidney Diseases
Risk stratification in early-stage Cardiovascular-Kidney-Metabolic Syndrome: The Potency of visceral adiposity and insulin resistance surrogate indices
Lingyan He, Hui Lin, Xiaofang Zhang, 凌秀凤 · 2026 · Diabetes Research and Clinical Practice
Association between C-reactive protein-triglyceride glucose related indices and all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome
Wenguang Lai, Yang Zhou, Louyi Xiao, Tingting Zhang, Wenbiao He, Junhao He, Wenjun Gu, Yucui Lin · 2026 · Cardiovascular Diabetology
Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults: Standards of Care in Overweight and Obesity—2026
Kimberly Anne Gudzune, Leigh Perreault, Caroline Margaret Apovian, Vanita R. Aroda, Louis J. Aronne, Angela Fitch, Stephanie L. Fitzpatrick, William Timothy Garvey, Scott I. Kahan, Kamlesh Khunti et al. · 2026 · Diabetes Obesity and Cardiometabolic CARE
Finerenone Prescriptions in the United States (2021–2024) by Physician Specialty: Analysis of Use and Potential in the Cardiovascular‐Kidney‐Metabolic Space
Yara A. Jelwan, Tianyu Cao, Zhiqi Yao, Semenawit Burka, John Erhabor, Phillip Berning, Omar Dildar a Dzaye, Michael Joseph Blaha · 2026 · Journal of the American Heart Association
Optimizing early triage for subclinical cardiovascular-kidney-metabolic syndrome: longitudinal associations, incremental value, and clinical utility of nine insulin resistance surrogates
Yingxiu Huang, Xiaoxiao Qu, Shenrui Xu, Peng Zhen, Mei Yao, Jun Luo, Ruyu Cui, Chi-E Qiu, Guosong Jiang, Jing Cheng · 2026 · Cardiovascular Diabetology
Newer and novel antidiabetic drug classes across the cardiovascular–kidney–metabolic continuum
Konstantinos Stefanakis, Paschalis Karakasis, Dimitra Vasdeki, Djordje S. Popovic, Dimitrios Patoulias, Manfredi Rizzo, Christos Socrates Mantzoros · 2026 · Endocrine Reviews
Association between the combined cholesterol, high-density lipoprotein, glucose index and frailty index and new-onset cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: evidence from CHARLS
Zhonghua Sun, Kexue Wang, Chiwei Guo, Jiajun Qiu, Wencai Wang, Yameng Xu, Yi Tang, Kaisaierjiang Kadier, Song Wen, Wei Zhang · 2026 · Cardiovascular Diabetology
Biomarker-guided pharmacotherapy in cardiovascular-kidney-metabolic syndrome: A three-dimensional framework for precision drug selection and monitoring
Yafeng Li, Wenzhu Song, Chengyu Huan, Keman Xu, Juan Sun, Xin Zhen, Hua Ouyang, Hairong Tang, Qiuxia Fan, Wenqiang Zhi et al. · 2026 · Pharmacology & Therapeutics
The therapeutic approach to cardiovascular–kidney–metabolic syndrome
Janani Rangaswami, Kevin Bryan Lo, Chiadi E. Ndumele · 2026 · Nature Reviews Nephrology
Social Factors Associated With CKM Stage—Is There Nothing New Under the Sun?
Amber E. Johnson, Jared W. Magnani · 2024 · JAMA Network Open
Effect of randomised blood pressure lowering treatment and intensive glucose control on dementia and cognitive decline according to baseline cognitive function and other subpopulations of individuals with type 2 diabetes: Results from the ADVANCE trial
Katie Harris, Jessica Gong, Stephen W MacMahon, Ying Hua Xu, Sultana Shajahan, Stephen B. Harrap, Neil R Poulter, Michel Marre, Pavel Hamet, Giuseppe Mancia et al. · 2024 · Cerebral Circulation - Cognition and Behavior
A Portuguese expert panel position paper on the management of heart failure with preserved ejection fraction – Part I: Pathophysiology, diagnosis and treatment
José Silva‐Cardoso, Emília Moreira, Rachel Tavares de Melo, Pedro Sarmento, Nuno Miguel Cardim, Mário Oliveira, Cristina Gavina, Brenda Moura, Inês Araújo, Paulo Roberto Santos et al. · 2025 · Revista Portuguesa de Cardiologia
Life's Essential 8, Cardiovascular Health, and CKD Progression among Hispanic/Latino Adults: The Hispanic Community Health Study/Study of Latinos Study
Amit K. Chakrabarti, Yelena R. Drexler, Samuel L. Swift, James Phillip Lash, Robert C. Kaplan, Krista M. Perreira, Jair Munoz Mendoza, Martha L. Daviglus, Amber Pirzada, Daniela Sotres‐Alvarez et al. · 2025 · Clinical Journal of the American Society of Nephrology
Prognosis of non-albuminuric patients with the cardiovascular–kidney–metabolic syndrome
Xiao Bi, Yue Shen, Yuqi Shen, Aiwen Shen, Shiyu Zhou, Wenji Wang, Xuezhu Li, Sheng Nie, Feng Hua Ding · 2025 · Clinical Kidney Journal
Occurrence and prognosis of chronic kidney disease in Denmark – a nationwide population-based cohort study
Simon Kok Jensen, Michael Lejbach Bertelsen, Søren Viborg Vestergaard, Mette Nørgaard, Reimar Wernich Thomsen, Henrik Birn, Uffe Heide‐Jørgensen, Christian Fynbo Christiansen · 2025 · Clinical Kidney Journal
Revisiting the benefits vs risk profile of sodium-glucose co-transporter inhibitor use in type 1 diabetes Part A: Benefits of sodium-glucose co-transporter inhibitor use in type 1 diabetes
Jennifer Ngan, David Norman O'Neal, Melissa H. Lee, Yee Wen Kong, Richard J. MacIsaac · 2025 · Diabetes Research and Clinical Practice
From the Cardiovascular–Kidney–Metabolic Disorders to the Atherosclerotic Cardiovascular Diseases: Their Prevalence Rates and Independent Associations in the SIMETAP Study
Antonio Ruiz‐García, Vicente Pallarés‐Carratalá, Adalberto Serrano-Cumplido, Vicente Pascual-Fuster, Ezequiel Arranz-Martínez, Carlos Escobar · 2025 · Journal of Clinical Medicine
Association of cross-life-cycle body size and genetic risk with cardio-renal-metabolic conditions in adulthood: evidence from a prospective cohort study
Chengdong Yu, Shuyuan Zhang, Huijing He, Feitong Wu, Shaoyuan Lei, Xinnan Zong, Yuxiu Li, Huabing Zhang, Shuyang Zhang · 2025 · International Journal of Surgery
Association Between the Ideal Cardiovascular Health Score and Cardiovascular-Kidney Outcomes in Young Adults
Hyeok‐Hee Lee, Jong Hyun Jhee, Eun‐Jin Kim, Dasom Son, Hyeon Chang Kim, Donald M. Lloyd‐Jones, Hokyou Lee · 2025 · American Journal of Kidney Diseases
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry
Paolo Lido, Silvia Cantiero, Antonio Galluccio, Annalisa Noce, Luca Di Lullo, Roberto Bei, Ferdinando Iellamo, Pier Mannuccio Mannucci, Alessandro Nobili, Mauro Tettamanti et al. · 2025 · Internal and Emergency Medicine
Global cardiometabolic alliance: A clinical and research initiative addressing the 21st century pandemic of insulin resistance‐associated disease
Robert H. Eckel, Andrew J. Krentz, Stephan Jacob, Peter Libby · 2025 · Diabetes Obesity and Metabolism
Galectin-3 Is Associated With Risk of Cardiovascular and Kidney Outcomes in Ambulatory Veterans
Shreya Banerjee, Pranav Sandilya Garimella, Kimberly N. Hong, Alexander L. Bullen, Lori B. Daniels, Nicholas W. Wettersten · 2025 · Kidney Medicine
Low Rates of MASLD Screening in Young Adults With Type 2 Diabetes: A Retrospective Cohort Study
Chloe de Crecy, Qiang yang, Mei Liu, Rui Yin, Anu Rani Sharma · 2025 · Journal of the Endocrine Society
Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD
Luis Ortega‐Paz, Francesco Franchi, Fabiana Rollini, Mattía Galli, Latonya F. Been, Ghussan Ghanem, Awss Shalhoub, Tiffany Ossi, Andrea Rivas, Xuan Zhou et al. · 2024 · JACC Basic to Translational Science
Sodium–glucose cotransporter 2 inhibitors reduce the risk of incident type 2 diabetes in people with heart failure without diabetes: An analysis of real‐world, cohort data
Alex E. Henney, David R. J. Riley, Megan Heague, Theresa Hydes, Matthew Anson, Uazman Alam, Daniel James Cuthbertson · 2024 · Diabetes Obesity and Metabolism
International Initiatives of the American Heart Association: Original Concepts, Present Programs, and Future Focus: A Science Advisory From the American Heart Association
Sidney C. Smith, Dhruv S. Kazi, Cheryl A.M. Anderson, Craig T. Beam, Douglas S. Boyle, Kelly Griesenbeck Carter, Mitchell S.V. Elkind, Pooja Khatri, John Meiners, Louise Morgan et al. · 2024 · Circulation
The promise and hope of GLP-1 receptor agonists
Priya Sumithran, Jamy D. Ard · 2024 · The Lancet Diabetes & Endocrinology
Landscape of cardiorenal syndrome research: A bibliometric analysis
Yan Sun, Bin Hua, Yan Bai, Wang Zheng, Lin Shen, Wangkang Niku, Yihong Wei, Fan Zhang, Bing Deng · 2024 · Medicine
Dietary Inflammatory Index Is Differentially Associated With Cardiometabolic Health After Pregnancy on the Basis of Adverse Pregnancy Outcome Exposure
McKenzie K. Jancsura, Michael D. Wirth, Nathan P. Helsabeck, Brian M. Mercer, David M. Haas, Philip Greenland, Rebecca B. McNeil, Lisa Danielle Levine, Robert M. Silver, Lynn M. Yee et al. · 2024 · Journal of the American Heart Association
Pump, pipes, filter, sugar, weight, and more: the pluripotent prowess of semaglutide
Subodh Verma, Francesco Cosentino, Mikhail Kosiborod · 2024 · European Heart Journal
Obesity management: a foundational cardiovascular health priority
John W. Ostrominski, Jorge Plutzky, Naveed A. Sattar, Muthiah Vaduganathan, Vanita R. Aroda · 2025 · European Journal of Preventive Cardiology
Protective effect of serum carotenoids on mortality among metabolic syndrome patients: attenuated by lipid-lowering drugs
Chunxiang Li, Yu Liang, Qiuyuan Lu, Yuanxin Lin, Shifeng Wen, Xiaoyu Luo, Shiping Huang, Xue Bing Zhong, Zhenhua Xu, Fei Wang · 2025 · Nutrition Journal
Is the very low carbohydrate diet safe for individuals with chronic kidney disease?
Brooke S. Colledge, Emma C. Schofield, B. B. Clarke, Gordana C. Popovic, Mohandas Vattekad, Penelope E. Figtree · 2025 · Journal of Metabolic Health
Unifying Efforts to Empower Equitable Obesity Care: Synopsis of an American College of Physicians and Council of Subspecialty Societies Summit.
Christina C. Wee, Alicia I. Arbaje, Harriet Bering, L. Blount, Joshua J Joseph, Scott Kahan, Caroline M. Apovian, Adrienne White-Faines · 2025 · Annals of Internal Medicine
How to Enhance Cardiorenal Benefits in Patients With Chronic Heart Failure?
Toshihide Izumida, Koichiro Kinugawa · 2025 · International Journal of Heart Failure